Skip to main content
Steven Dubinett, MD, Pulmonology, Los Angeles, CA

StevenM.DubinettMD

Pulmonology • Los Angeles, CA

Professor, Medicine, UCLA School of Medicine

Join to view full profile

Dr. Dubinett is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Dubinett's full profile

Already have an account?

  • Office

    10833 Le Conte Avenue
    43-229 CHS
    Los Angeles, CA 90095
    Phone+1 310-267-2725
    Fax+1 310-267-2725

Education & Training

  • Harvard Medical School
    Harvard Medical SchoolFellowship, Cancer Immunology, 1986 - 1988
  • Massachusetts General Hospital/BIDMC/Harvard Medical School
    Massachusetts General Hospital/BIDMC/Harvard Medical SchoolResidency, Pulmonary Disease and Critical Care Medicine, 1985 - 1988
  • UCLA-VA Greater Los Angeles
    UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1981 - 1984
  • Rutgers Health/New Jersey Medical School
    Rutgers Health/New Jersey Medical SchoolInternship, Internal Medicine, 1980 - 1981
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1981 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Functional Profiling of Circulating Tumor Cells with an Integrated Vortex Capture and Single-Cell Protease Activity Assay  
    Steven M Dubinett, Matthew B Rettig, Proceedings of the National Academy of Sciences

Press Mentions

  • UCLA Receives $20 Million from Saul and Joyce Brandman Foundation for New Lung Health Center
    UCLA Receives $20 Million from Saul and Joyce Brandman Foundation for New Lung Health CenterMarch 6th, 2025
  • UCLA’s Dr. Donna Washington Elected to the National Academy of Medicine
    UCLA’s Dr. Donna Washington Elected to the National Academy of MedicineOctober 21st, 2024
  • Genetically Engineered Dendritic Cells Enhance the Power of Immunotherapy Against Lung Cancer
    Genetically Engineered Dendritic Cells Enhance the Power of Immunotherapy Against Lung CancerMarch 26th, 2024
  • Join now to see all

Grant Support

  • Evaluation of PARP7 dependency as a novel therapeutic target for non-small cell lung cancerVA GREATER LOS ANGELES HEALTHCARE SYSTEM2024–2028
  • UCLA Tumor Immunology Institutional Training GrantUNIVERSITY OF CALIFORNIA LOS ANGELES1980–2028
  • UCLA Tumor Immunology Institutional Training GrantUNIVERSITY OF CALIFORNIA LOS ANGELES1980–2028
  • The Boston University - UCLA Lung Cancer Biomarker Characterization CenterBOSTON UNIVERSITY MEDICAL CAMPUS2022–2027
  • UCLA Clinical and Translational Science InstituteUNIVERSITY OF CALIFORNIA LOS ANGELES2016–2027
  • The Lung PCA: A Multi-Dimensional Atlas of Pulmonary PremalignancyBOSTON UNIVERSITY MEDICAL CAMPUS2018–2025
  • UCLA Pulmonary and Critical Care Medicine Training ProgramUNIVERSITY OF CALIFORNIA LOS ANGELES2003–2025
  • Intratumoral Genetic Therapy For Lung CancerVeterans Affairs2012
  • Inflammation In The Pathogenesis Of Lung CancerVeterans Affairs2011–2012
  • UCLA Clinical And Translational Science InstituteNational Center For Research Resources2011
  • CTSA Infrastructure For Pediatric ResearchNational Center For Research Resources2011
  • CTSA Infrastructure For Clinical TrialsNational Center For Research Resources2011
  • CTSA Infrastructure For AIDS ResearchNational Center For Research Resources2011
  • The UCLA - Boston University Lung Cancer Biomarker Development LaboratoryNational Cancer Institute2010–2011
  • Thoracic OncologyNational Cancer Institute2009–2011
  • Novel COX-2 And Pge2-Dependent Pathways In Lung CancerNational Cancer Institute2006–2010
  • UCLA Spore In Lung CancerNational Cancer Institute2001–2008
  • A Phase I Trial Of Ccl-21 Gene Modified DC In NsclcNational Cancer Institute2003–2007
  • New Pathways In IL7 Mediated Antifibrotic ResponsesNational Heart, Lung, And Blood Institute2002–2005
  • Genetic Immunotherapy For Lung CancerNational Cancer Institute2001–2004
  • Dendritic Cell-Based Genetic Immunotherapy /Lung CancerNational Cancer Institute2001–2002
  • New Pathways In IL7 Mediated Antifibrotic ResponsesNational Heart, Lung, And Blood Institute2001
  • Function And Regulation Of IL 10 In Lung CancerNational Cancer Institute1997–2001

Dr. Steven Dubinett, Dr. Steven Dubinett, MD, Dr. S Dubinett, Dr. Steven M. Dubinett